Acceleration of the Development of Alzheimer’s Disease in Amyloid Beta-Infused Peroxiredoxin 6 Overexpression Transgenic Mice

The amyloid beta (Aβ) peptide in the brains of patients with Alzheimer’s disease (AD) is cytotoxic to neurons and has a central role in the pathogenesis of the disease. Peroxiredoxin 6 (Prdx6) is an antioxidant protein and could act as a cytoprotective protein. However, the role of Prdx6 in neurodeg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular neurobiology 2013-12, Vol.48 (3), p.941-951
Hauptverfasser: Yun, Hyung-Mun, Jin, Peng, Han, Jin-Yi, Lee, Moon-Soon, Han, Sang-Bae, Oh, Ki-Wan, Hong, Sung-Han, Jung, Eun-Yong, Hong, Jin Tae
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 951
container_issue 3
container_start_page 941
container_title Molecular neurobiology
container_volume 48
creator Yun, Hyung-Mun
Jin, Peng
Han, Jin-Yi
Lee, Moon-Soon
Han, Sang-Bae
Oh, Ki-Wan
Hong, Sung-Han
Jung, Eun-Yong
Hong, Jin Tae
description The amyloid beta (Aβ) peptide in the brains of patients with Alzheimer’s disease (AD) is cytotoxic to neurons and has a central role in the pathogenesis of the disease. Peroxiredoxin 6 (Prdx6) is an antioxidant protein and could act as a cytoprotective protein. However, the role of Prdx6 in neurodegenerative disease has not been studied. Thus, the roles and action mechanisms in the development of AD were examined. Aβ 1–42 -induced memory impairment in Prdx6 transgenic mice was worse than C57BL/6 mice, and the expression of amyloid precursor protein cleavage, C99, β-site APP-cleaving enzyme 1, inducible nitric oxide synthase, and cyclooxygenase-2 was greatly increased. In addition, the astrocytes and microglia cells of Aβ-infused Prdx6 transgenic mice were more activated, and Aβ also significantly increased lipid peroxidation and protein carbonyl levels, but decreased glutathione levels. Furthermore, we found that translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) to the nucleus was increased in Aβ-infused Prdx6 transgenic mice. These results suggest that the overexpression of Prdx6 could accelerate the development of AD through increased amyloidogenesis through independent PLA2 activation and Nrf2 transcription.
doi_str_mv 10.1007/s12035-013-8479-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1448960313</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3119676981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-b368de27834a76da2d0e5f4ef4bad815adb86a0652a19e850ecef442f37fda003</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EouXxAWyQJdYGPxLbWZbylECwgLXlxhNwlTjFTitgA7_B7_ElpCogNmxmpLl37pUOQnuMHjJK1VFinIqcUCaIzlRB5BoasjwvCGOar6Mh1YUgSmZ6gLZSmlLKOaNqEw24UIppJofobVSWUEO0nW8DbivcPQI-gQXU7ayB0C1Po_r1EXwD8fP9I-ETn8AmwD7gUfNSt97hY-gsuQzVPIHDtxDbZx_B9TNgiW8WEOF5FiGlZcVdtCE9QPAlvvYl7KCNytYJdr_3Nro_O70bX5Crm_PL8eiKlELxjkyE1A640iKzSjrLHYW8yqDKJtZplls30dJSmXPLCtA5hbLXMl4JVTlLqdhGB6vcWWyf5pA6M23nMfSVhmWZLiQVTPQutnKVsU0pQmVm0Tc2vhhGzRK5WSE3PXKzRG5k_7P_nTyfNOB-P34Y9wa-MqReCg8Q_1T_m_oFbSaO2Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1448960313</pqid></control><display><type>article</type><title>Acceleration of the Development of Alzheimer’s Disease in Amyloid Beta-Infused Peroxiredoxin 6 Overexpression Transgenic Mice</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Yun, Hyung-Mun ; Jin, Peng ; Han, Jin-Yi ; Lee, Moon-Soon ; Han, Sang-Bae ; Oh, Ki-Wan ; Hong, Sung-Han ; Jung, Eun-Yong ; Hong, Jin Tae</creator><creatorcontrib>Yun, Hyung-Mun ; Jin, Peng ; Han, Jin-Yi ; Lee, Moon-Soon ; Han, Sang-Bae ; Oh, Ki-Wan ; Hong, Sung-Han ; Jung, Eun-Yong ; Hong, Jin Tae</creatorcontrib><description>The amyloid beta (Aβ) peptide in the brains of patients with Alzheimer’s disease (AD) is cytotoxic to neurons and has a central role in the pathogenesis of the disease. Peroxiredoxin 6 (Prdx6) is an antioxidant protein and could act as a cytoprotective protein. However, the role of Prdx6 in neurodegenerative disease has not been studied. Thus, the roles and action mechanisms in the development of AD were examined. Aβ 1–42 -induced memory impairment in Prdx6 transgenic mice was worse than C57BL/6 mice, and the expression of amyloid precursor protein cleavage, C99, β-site APP-cleaving enzyme 1, inducible nitric oxide synthase, and cyclooxygenase-2 was greatly increased. In addition, the astrocytes and microglia cells of Aβ-infused Prdx6 transgenic mice were more activated, and Aβ also significantly increased lipid peroxidation and protein carbonyl levels, but decreased glutathione levels. Furthermore, we found that translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) to the nucleus was increased in Aβ-infused Prdx6 transgenic mice. These results suggest that the overexpression of Prdx6 could accelerate the development of AD through increased amyloidogenesis through independent PLA2 activation and Nrf2 transcription.</description><identifier>ISSN: 0893-7648</identifier><identifier>EISSN: 1559-1182</identifier><identifier>DOI: 10.1007/s12035-013-8479-6</identifier><identifier>PMID: 23771816</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Alzheimer Disease - complications ; Alzheimer Disease - enzymology ; Alzheimer Disease - pathology ; Alzheimer's disease ; Amyloid beta-Peptides - toxicity ; Amyloid Precursor Protein Secretases - metabolism ; Animals ; Aspartic Acid Endopeptidases - metabolism ; Astrocytes - drug effects ; Astrocytes - enzymology ; Astrocytes - pathology ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Cyclooxygenase 2 - metabolism ; Disease Progression ; Female ; Gene expression ; Glutathione - metabolism ; Lipid Peroxidation - drug effects ; Memory Disorders - complications ; Memory Disorders - enzymology ; Memory Disorders - pathology ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Microglia - drug effects ; Microglia - enzymology ; Microglia - pathology ; Neurobiology ; Neurodegeneration ; Neurology ; Neurosciences ; NF-E2-Related Factor 2 - genetics ; NF-E2-Related Factor 2 - metabolism ; Nitric Oxide Synthase Type II - metabolism ; Oxidative Stress - drug effects ; Pathogenesis ; Peroxiredoxin VI - metabolism ; Phospholipases A2 - metabolism ; Protein Carbonylation - drug effects ; Proteins ; Transcription, Genetic - drug effects ; Transgenic animals</subject><ispartof>Molecular neurobiology, 2013-12, Vol.48 (3), p.941-951</ispartof><rights>Springer Science+Business Media New York 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-b368de27834a76da2d0e5f4ef4bad815adb86a0652a19e850ecef442f37fda003</citedby><cites>FETCH-LOGICAL-c372t-b368de27834a76da2d0e5f4ef4bad815adb86a0652a19e850ecef442f37fda003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12035-013-8479-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12035-013-8479-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23771816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yun, Hyung-Mun</creatorcontrib><creatorcontrib>Jin, Peng</creatorcontrib><creatorcontrib>Han, Jin-Yi</creatorcontrib><creatorcontrib>Lee, Moon-Soon</creatorcontrib><creatorcontrib>Han, Sang-Bae</creatorcontrib><creatorcontrib>Oh, Ki-Wan</creatorcontrib><creatorcontrib>Hong, Sung-Han</creatorcontrib><creatorcontrib>Jung, Eun-Yong</creatorcontrib><creatorcontrib>Hong, Jin Tae</creatorcontrib><title>Acceleration of the Development of Alzheimer’s Disease in Amyloid Beta-Infused Peroxiredoxin 6 Overexpression Transgenic Mice</title><title>Molecular neurobiology</title><addtitle>Mol Neurobiol</addtitle><addtitle>Mol Neurobiol</addtitle><description>The amyloid beta (Aβ) peptide in the brains of patients with Alzheimer’s disease (AD) is cytotoxic to neurons and has a central role in the pathogenesis of the disease. Peroxiredoxin 6 (Prdx6) is an antioxidant protein and could act as a cytoprotective protein. However, the role of Prdx6 in neurodegenerative disease has not been studied. Thus, the roles and action mechanisms in the development of AD were examined. Aβ 1–42 -induced memory impairment in Prdx6 transgenic mice was worse than C57BL/6 mice, and the expression of amyloid precursor protein cleavage, C99, β-site APP-cleaving enzyme 1, inducible nitric oxide synthase, and cyclooxygenase-2 was greatly increased. In addition, the astrocytes and microglia cells of Aβ-infused Prdx6 transgenic mice were more activated, and Aβ also significantly increased lipid peroxidation and protein carbonyl levels, but decreased glutathione levels. Furthermore, we found that translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) to the nucleus was increased in Aβ-infused Prdx6 transgenic mice. These results suggest that the overexpression of Prdx6 could accelerate the development of AD through increased amyloidogenesis through independent PLA2 activation and Nrf2 transcription.</description><subject>Alzheimer Disease - complications</subject><subject>Alzheimer Disease - enzymology</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Amyloid beta-Peptides - toxicity</subject><subject>Amyloid Precursor Protein Secretases - metabolism</subject><subject>Animals</subject><subject>Aspartic Acid Endopeptidases - metabolism</subject><subject>Astrocytes - drug effects</subject><subject>Astrocytes - enzymology</subject><subject>Astrocytes - pathology</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Cyclooxygenase 2 - metabolism</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Gene expression</subject><subject>Glutathione - metabolism</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Memory Disorders - complications</subject><subject>Memory Disorders - enzymology</subject><subject>Memory Disorders - pathology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Transgenic</subject><subject>Microglia - drug effects</subject><subject>Microglia - enzymology</subject><subject>Microglia - pathology</subject><subject>Neurobiology</subject><subject>Neurodegeneration</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>NF-E2-Related Factor 2 - genetics</subject><subject>NF-E2-Related Factor 2 - metabolism</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Oxidative Stress - drug effects</subject><subject>Pathogenesis</subject><subject>Peroxiredoxin VI - metabolism</subject><subject>Phospholipases A2 - metabolism</subject><subject>Protein Carbonylation - drug effects</subject><subject>Proteins</subject><subject>Transcription, Genetic - drug effects</subject><subject>Transgenic animals</subject><issn>0893-7648</issn><issn>1559-1182</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kMtOwzAQRS0EouXxAWyQJdYGPxLbWZbylECwgLXlxhNwlTjFTitgA7_B7_ElpCogNmxmpLl37pUOQnuMHjJK1VFinIqcUCaIzlRB5BoasjwvCGOar6Mh1YUgSmZ6gLZSmlLKOaNqEw24UIppJofobVSWUEO0nW8DbivcPQI-gQXU7ayB0C1Po_r1EXwD8fP9I-ETn8AmwD7gUfNSt97hY-gsuQzVPIHDtxDbZx_B9TNgiW8WEOF5FiGlZcVdtCE9QPAlvvYl7KCNytYJdr_3Nro_O70bX5Crm_PL8eiKlELxjkyE1A640iKzSjrLHYW8yqDKJtZplls30dJSmXPLCtA5hbLXMl4JVTlLqdhGB6vcWWyf5pA6M23nMfSVhmWZLiQVTPQutnKVsU0pQmVm0Tc2vhhGzRK5WSE3PXKzRG5k_7P_nTyfNOB-P34Y9wa-MqReCg8Q_1T_m_oFbSaO2Q</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Yun, Hyung-Mun</creator><creator>Jin, Peng</creator><creator>Han, Jin-Yi</creator><creator>Lee, Moon-Soon</creator><creator>Han, Sang-Bae</creator><creator>Oh, Ki-Wan</creator><creator>Hong, Sung-Han</creator><creator>Jung, Eun-Yong</creator><creator>Hong, Jin Tae</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QR</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20131201</creationdate><title>Acceleration of the Development of Alzheimer’s Disease in Amyloid Beta-Infused Peroxiredoxin 6 Overexpression Transgenic Mice</title><author>Yun, Hyung-Mun ; Jin, Peng ; Han, Jin-Yi ; Lee, Moon-Soon ; Han, Sang-Bae ; Oh, Ki-Wan ; Hong, Sung-Han ; Jung, Eun-Yong ; Hong, Jin Tae</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-b368de27834a76da2d0e5f4ef4bad815adb86a0652a19e850ecef442f37fda003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Alzheimer Disease - complications</topic><topic>Alzheimer Disease - enzymology</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Amyloid beta-Peptides - toxicity</topic><topic>Amyloid Precursor Protein Secretases - metabolism</topic><topic>Animals</topic><topic>Aspartic Acid Endopeptidases - metabolism</topic><topic>Astrocytes - drug effects</topic><topic>Astrocytes - enzymology</topic><topic>Astrocytes - pathology</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Cyclooxygenase 2 - metabolism</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Gene expression</topic><topic>Glutathione - metabolism</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Memory Disorders - complications</topic><topic>Memory Disorders - enzymology</topic><topic>Memory Disorders - pathology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Transgenic</topic><topic>Microglia - drug effects</topic><topic>Microglia - enzymology</topic><topic>Microglia - pathology</topic><topic>Neurobiology</topic><topic>Neurodegeneration</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>NF-E2-Related Factor 2 - genetics</topic><topic>NF-E2-Related Factor 2 - metabolism</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Oxidative Stress - drug effects</topic><topic>Pathogenesis</topic><topic>Peroxiredoxin VI - metabolism</topic><topic>Phospholipases A2 - metabolism</topic><topic>Protein Carbonylation - drug effects</topic><topic>Proteins</topic><topic>Transcription, Genetic - drug effects</topic><topic>Transgenic animals</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yun, Hyung-Mun</creatorcontrib><creatorcontrib>Jin, Peng</creatorcontrib><creatorcontrib>Han, Jin-Yi</creatorcontrib><creatorcontrib>Lee, Moon-Soon</creatorcontrib><creatorcontrib>Han, Sang-Bae</creatorcontrib><creatorcontrib>Oh, Ki-Wan</creatorcontrib><creatorcontrib>Hong, Sung-Han</creatorcontrib><creatorcontrib>Jung, Eun-Yong</creatorcontrib><creatorcontrib>Hong, Jin Tae</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Molecular neurobiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yun, Hyung-Mun</au><au>Jin, Peng</au><au>Han, Jin-Yi</au><au>Lee, Moon-Soon</au><au>Han, Sang-Bae</au><au>Oh, Ki-Wan</au><au>Hong, Sung-Han</au><au>Jung, Eun-Yong</au><au>Hong, Jin Tae</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acceleration of the Development of Alzheimer’s Disease in Amyloid Beta-Infused Peroxiredoxin 6 Overexpression Transgenic Mice</atitle><jtitle>Molecular neurobiology</jtitle><stitle>Mol Neurobiol</stitle><addtitle>Mol Neurobiol</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>48</volume><issue>3</issue><spage>941</spage><epage>951</epage><pages>941-951</pages><issn>0893-7648</issn><eissn>1559-1182</eissn><abstract>The amyloid beta (Aβ) peptide in the brains of patients with Alzheimer’s disease (AD) is cytotoxic to neurons and has a central role in the pathogenesis of the disease. Peroxiredoxin 6 (Prdx6) is an antioxidant protein and could act as a cytoprotective protein. However, the role of Prdx6 in neurodegenerative disease has not been studied. Thus, the roles and action mechanisms in the development of AD were examined. Aβ 1–42 -induced memory impairment in Prdx6 transgenic mice was worse than C57BL/6 mice, and the expression of amyloid precursor protein cleavage, C99, β-site APP-cleaving enzyme 1, inducible nitric oxide synthase, and cyclooxygenase-2 was greatly increased. In addition, the astrocytes and microglia cells of Aβ-infused Prdx6 transgenic mice were more activated, and Aβ also significantly increased lipid peroxidation and protein carbonyl levels, but decreased glutathione levels. Furthermore, we found that translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) to the nucleus was increased in Aβ-infused Prdx6 transgenic mice. These results suggest that the overexpression of Prdx6 could accelerate the development of AD through increased amyloidogenesis through independent PLA2 activation and Nrf2 transcription.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>23771816</pmid><doi>10.1007/s12035-013-8479-6</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0893-7648
ispartof Molecular neurobiology, 2013-12, Vol.48 (3), p.941-951
issn 0893-7648
1559-1182
language eng
recordid cdi_proquest_journals_1448960313
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Alzheimer Disease - complications
Alzheimer Disease - enzymology
Alzheimer Disease - pathology
Alzheimer's disease
Amyloid beta-Peptides - toxicity
Amyloid Precursor Protein Secretases - metabolism
Animals
Aspartic Acid Endopeptidases - metabolism
Astrocytes - drug effects
Astrocytes - enzymology
Astrocytes - pathology
Biomedical and Life Sciences
Biomedicine
Cell Biology
Cyclooxygenase 2 - metabolism
Disease Progression
Female
Gene expression
Glutathione - metabolism
Lipid Peroxidation - drug effects
Memory Disorders - complications
Memory Disorders - enzymology
Memory Disorders - pathology
Mice
Mice, Inbred C57BL
Mice, Transgenic
Microglia - drug effects
Microglia - enzymology
Microglia - pathology
Neurobiology
Neurodegeneration
Neurology
Neurosciences
NF-E2-Related Factor 2 - genetics
NF-E2-Related Factor 2 - metabolism
Nitric Oxide Synthase Type II - metabolism
Oxidative Stress - drug effects
Pathogenesis
Peroxiredoxin VI - metabolism
Phospholipases A2 - metabolism
Protein Carbonylation - drug effects
Proteins
Transcription, Genetic - drug effects
Transgenic animals
title Acceleration of the Development of Alzheimer’s Disease in Amyloid Beta-Infused Peroxiredoxin 6 Overexpression Transgenic Mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A55%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acceleration%20of%20the%20Development%20of%20Alzheimer%E2%80%99s%20Disease%20in%20Amyloid%20Beta-Infused%20Peroxiredoxin%206%20Overexpression%20Transgenic%20Mice&rft.jtitle=Molecular%20neurobiology&rft.au=Yun,%20Hyung-Mun&rft.date=2013-12-01&rft.volume=48&rft.issue=3&rft.spage=941&rft.epage=951&rft.pages=941-951&rft.issn=0893-7648&rft.eissn=1559-1182&rft_id=info:doi/10.1007/s12035-013-8479-6&rft_dat=%3Cproquest_cross%3E3119676981%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1448960313&rft_id=info:pmid/23771816&rfr_iscdi=true